HYMOVIS® (German)

• alleviates pain, stiffness, and swelling associated with joint inflammation that comes about as a result of osteoarthritis of the knee
• helps prevent progression of osteoarthritis, protecting against further joint damage and preserving mobility
• used when other first-line medications like pain medication, NSAIDs or physical therapy have not provided optimal symptomatic improvement

• Proprietary process: Hymovis gel is manufactured without cross-linking, yet results in a highly viscoelastic product.
• Greater joint residence time: Hymovis product stays in the joint longer than other hyaluronic acid gels, resulting in longer-lasting effects (up to six months).
• Non-animal hyaluronic acid: Minimizes risk of allergic reactions.

Hymovis is made of high molecular weight hyaluronic acid (8 mg/ml concentration), dissolved in physiologic saline, that has been processed to form a hydrogel, called HYADD4. The hydrogel is a result of a proprietary manufacturing process that does not involve cross-linking. When injected, the Hymovis product lubricates and cushions the joint, supplementing the function originally served by synovial fluid.

• 2 x disposable 5 mL pre-filled syringes
• Package insert